KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 119 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $496,176 | +299.0% | 51,524 | +180.1% | 0.00% | – |
| Q4 2022 | $124,357 | -90.6% | 18,396 | -86.2% | 0.00% | -100.0% |
| Q2 2022 | $1,316,000 | +145.5% | 133,687 | +267.7% | 0.00% | +200.0% |
| Q1 2022 | $536,000 | +31.7% | 36,359 | +113.9% | 0.00% | -50.0% |
| Q2 2021 | $407,000 | -57.7% | 16,996 | -54.6% | 0.00% | -50.0% |
| Q1 2021 | $962,000 | +582.3% | 37,443 | +102.9% | 0.00% | +300.0% |
| Q1 2020 | $141,000 | -91.6% | 18,454 | -68.7% | 0.00% | -87.5% |
| Q1 2019 | $1,686,000 | – | 58,904 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |